p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours

Cancer Detection and Prevention

Volumn 28, Issue 4, 2004, Pages 252-259

  Paluszkiewicz, Piotr ^a   Berbeć, Henryk ^a   Pawłowska Wakowicz, Barbara ^b   Cybulski, Marek ^a   Paszkowska, Alicja ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Histopathological Unit   (Poland)

Author keywords

Cancer prognosis; Colorectal cancer; Immunohistochemistry; p53 protein; Western blotting

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12344252658     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.05.001     Document Type: Article

References (38)

1. Lane D.P., Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278:1979;261-263
2. Benhattar J., Cerottini J.P., Saraga E., et al. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int. J. Cancer. 69:1996;190-192
3. Bossari S., Viale G., Bossi P., et al. Cytoplasmatic acumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J. Natl. Cancer Inst. 86:1994;681-687
4. Carson D.A., Lois A. Cancer progression and p53. Lancet. 346:1995;1009-1012
5. Lothe R.A. Molecular genetic studies of tumour suppressor gene regions on chromosomes 13 and 17 in colorectal tumours. J. Natl. Cancer Inst. 84:1992;1100-1108
6. Yamada Y. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res. 51:1991;5800-5805
7. Harris C.C., Holstein M. Clinical implications of the tumor-suppressor gene. N. Engl. J. Med. 28:1993;1318-1327
8. Kinzler K.W., Vogelstein B. Cancer therapy meets p53. N Engl. J. Med. 33:1994;49-50
9. Jass J.R., Talbot I.C. Molecular and cellular biology of pre-malignancy in the gastrointestinal tract. Best Pract Res. Clin. Gastroenterol. 15:2001;175-189
10. Scott N. Molecular biology in colorectal neoplasia. Gut. 34:1993;289-292
11. Vesculescu V.E., El-Deiry W.S. Biological and clinical importance of the p53 tumor suppressor gene. Clin. Chem. 42:1996;858-868
12. Vogelstein B. Carcinogenesis leave fingerprints. Nature. 355:1992;209-210
13. Hanski C., Tiecke F., Hummel M., et al. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett. 103:1996;163-170
14. Remvikos Y., Tominaga O., Hammel P., et al. Increased p53 protein content of colorectal tumours correlates with poor survival. Br. J. Cancer. 66:1992;758-764
15. Shaw P. Occurrence of Ki-ras and p53 mutations in primary colorectal tumours. Oncogene. 6:1991;2121-2128
16. Starzyñska T., Bromley M., Ghosh A., et al. Prognostic significance of p53 overexpression in gastric and colorectal carcinomas. Br. J. Cancer. 66:1992;558-562
17. Vermeulen P.B., Roland L., Mertens V., et al. Correlation of intratumoral microvessel density and p53 overexpression in human colorectal adenocarcinoma. Microvasc Res. 51:1996;164-174
18. Fu C.G., Tominaga O., Nagawa H. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis. Colon Rectum. 41:1998;68-74
19. Qiu H., Sirivongs P., Rothenberger M., et al. Molecular prognostic factors in rectal cancer treated by radiation and surgery. Dis. Colon Rectum. 43:2000;451-459
20. Iacopetta B.J., Welch J., Soong R., et al. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alternations. J. Pathol. 184:1998;390-395
21. Ilyas M., Tomlinson I.P., Novelli M.R., et al. Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J. Pathol. 179:1996;370-375
22. Forster S., Sattler H.P., Hack M., et al. Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content negative protein expression of p53 and distinct histomorphologic features. Surgery. 123:1998;13-18
23. Watatani M., Yoshida T., Kuroda K., et al. Allelic loss of chromosome 17p mutation of the p53 gene and microsatelite instability in right- and left-sided colorectal cancer. Cancer. 77:1996;1688-1693
24. Lynch H.T., Smyrk T., Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet. 93:1997;84-89
25. Colon and rectum. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997. p. 83-90.
26. Houbiers J.G.A., Brand A., Van de Watering L.M.G., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 344:1994;573-578
27. Nowacki M.P., Janik P., Nowacki P.M. Inflamation and metastases. Med Hypotheses. 47:1996;193-196
28. Taylor I. Colorectal cancer - future trends. Eur. J. Surg. Oncol. 21:1995;351-352
29. Kikuchi-Yanoshita R. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familiar adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 52:1992;3965-3971
30. Ponz de Leon M., Sassatelli R., Benatti P., et al. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry. Cancer. 71:1993;3493-3501
31. Rew D.A., Karkera R., Mullee M.A., et al. The flow cytometric analysis of total p53 protein content and proliferation indices in colorectal cancer, in relation to clinical outcome. Eur. J. Surg. Oncol. 22:1996;508-515
32. Prioleau J., Schnitt S.J. p53 antigen loss in stored paraffin slides. N. Engl. J. Med. 332:1995;1521-1522
33. Paluszkiewicz P., Pawłowska-Wakowicz B., Cybulski M., et al. Białko p53 w gruczolakorakach jelita grubego [P53 protein in adenocarcinoma of the large intestine]. Wiad Lek. 50:1997;87-91
34. Iacopetta B. Are there two sides to colorectal cancer? Int. J. Cancer. 101:2002;403-408
35. Soong R., Grieu F., Robbins P., et al. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin. Cancer Res. 3:1997;1405-1411
36. Young J., Simms L.A., Biden K.G., et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am. J. Pathol. 159:2001;2107-2116
37. Bossman F.T., Visser B.C., Van Oeveren J. Apoptosis: pathophysiology of programmed cell death. Path. Res. Pract. 192:1996;676-683
38. Jannot M.C., Yeaton P., Pauwels O. Chemiotherapy induced nuclear alternations of morphologic and genomic characteristics in a human colon cancer grafted onto nude mouse. Dis. Colon Rectum. 38:1995;853-865